New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2013
17:08 EDTHSPHospira stock could surge with successful inspection of facility, Barron's says
Hospira's (HSP) Rocky Mount drug manufacturing facility could be inspected by the FDA in the first half of this year. If the facility passes the inspection, it would increase the company's production and allow the company to expand into other markets, according to Barron's. Reference Link
News For HSP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 20, 2014
08:04 EDTHSPGerman fund pressured to sell Mylan stake over drug used in executions, FT says
Subscribe for More Information
October 19, 2014
14:18 EDTHSPFresenius, others explore bid for Danone medical nutrition unit, Reuters says
Subscribe for More Information
October 14, 2014
11:23 EDTHSPBIND Therapeutics and The Conference Forum hold a conference
Subscribe for More Information
October 8, 2014
13:00 EDTHSPHospira recalling one lot of Vancomycin Hydrochloride
The FDA announced that Hospira is initiating a voluntary nationwide user-level recall of one lot of Vancomycin Hydrochloride. The action is because the product may have experienced temperature excursions during shipment to a customer and then was further distributed by the customer, the agency said. It added that there have been no adverse events or complaints reported for the affected lot. Hospira is "undertaking the recall out of an abundance of caution," the FDA said.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use